Idorsia Ltd
SIX:IDIA

Watchlist Manager
Idorsia Ltd Logo
Idorsia Ltd
SIX:IDIA
Watchlist
Price: 0.917 CHF 1.44% Market Closed
Market Cap: 165.3m CHF

Idorsia Ltd
Total Equity

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Idorsia Ltd
Total Equity Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Total Equity CAGR 3Y CAGR 5Y CAGR 10Y
Idorsia Ltd
SIX:IDIA
Total Equity
-CHf968.7m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
AC Immune SA
NASDAQ:ACIU
Total Equity
CHf130.2m
CAGR 3-Years
-10%
CAGR 5-Years
-15%
CAGR 10-Years
N/A
CRISPR Therapeutics AG
NASDAQ:CRSP
Total Equity
$1.9B
CAGR 3-Years
-8%
CAGR 5-Years
27%
CAGR 10-Years
N/A
Molecular Partners AG
SIX:MOLN
Total Equity
CHf155.6m
CAGR 3-Years
5%
CAGR 5-Years
15%
CAGR 10-Years
N/A
Basilea Pharmaceutica AG
SIX:BSLN
Total Equity
CHf16.8m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
-14%
Kuros Biosciences AG
SIX:KURN
Total Equity
CHf60.2m
CAGR 3-Years
-11%
CAGR 5-Years
-3%
CAGR 10-Years
N/A

Idorsia Ltd
Glance View

Market Cap
172.7m CHF
Industry
Biotechnology

Idorsia Ltd. operates as a biopharmaceutical firm which focuses on discovery, development and commercialization of innovative medicines for unmet medical needs. The company is headquartered in Allschwil, Basel-Landschaft. The company went IPO on 2017-06-16. The firm will have a diverse clinical development pipeline comprising several compounds being investigated in multiple therapeutic areas, including central nervous system disorders, cardiovascular disorders, immunological disorders and orphan diseases. The firm's development compounds target a number of different diseases such as: Resistant Hypertension, Systemic lupus erythematosus, Chronic insomnia and Fabry disease, among others.

IDIA Intrinsic Value
Not Available

See Also

What is Idorsia Ltd's Total Equity?
Total Equity
-968.7m CHF

Based on the financial report for Dec 31, 2023, Idorsia Ltd's Total Equity amounts to -968.7m CHF.

What is Idorsia Ltd's Total Equity growth rate?
Total Equity CAGR 1Y
-47%

Over the last year, the Total Equity growth was -47%.

Back to Top